regn4336
Showing 1 - 1 of 1
Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- REGN4336
- +2 more
-
Palo Alto, California
- +8 more
Jan 17, 2023